Increased public awareness of drug safety, stringent regulatory requirements and a number of recent drug withdrawals are forcing pharmaceutical companies to rethink how they ensure the clinical and post-market safety of their products. With every product on the market, companies have to think ahead and prepare risk management plans as a part of increased drug safety procedure.
Through a series of presentations and interactive discussions, participants will gain new insight and share hands-on experiences with leading companies in the pharma industry who have learnt to use pharmacovigilance and risk management both effectively and profitably.
|
